Products

Anti-gp240 antigen Immunocytokine, scFv (scFvMEL)-GrB (ACFP-SH067)

This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-gp240 antigen scFv to GrB. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the gp240 antigen as well as the biological activity of GrB. The GrB/scFvMEL fusion construct demonstrates impressive antitumor activity and enhances the sensitivity of human melanoma cells to chemotherapy. This immunocytokine was designed for treating melanoma.      

Specifications
Target
gp240 antigen
Molecule Class
scFv-GrB
Species Reactivity
Human
Host
Mouse
Expression Host
CHO
Clone
ZME-018 (scFvMEL)
Related Disease
Melanoma
Cytokines 1
GrB
Cytokines 1 Description
The serine protease granzyme B (GrB) is integrally involved in apoptotic cell death induced in target cells upon their exposure to the contents of lysosome-like cytoplasmic granules (or cytolytic granules) found in cytotoxic T-lymphocytes (CTL) and natural killer (NK) cells. Cytotoxic lymphocyte granules contain perforin, a pore-forming protein, and a family of serine proteases, termed granzymes.
Cytokine 1 Species
Human
Applications
This product can be used therapeutically to deliver biologically active ligands to a desired tissue.
Target
Alternative Names
gp240 antigen

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved